title: [Usefulness of BNP measurement for stratifying cardiovascular risk in hypertensive patients].
abstract: The production of brain natriuretic peptide (BNP) by ventricular cardiomyocytes is increased in patients with left ventricular hypertrophy (LVH). Increased plasma levels of BNP or of the inactive fragment NP-proBNP are associated with an increased cardiovascular risk. The measurement of plasma concentrations of these peptides may be useful for stratifying the cardiovascular risk of hypertensive patients, particularly if there is no electrocardiographic evidence for LVH.
authors.affiliation: Division de physiopathologie clinique, CHUV, MP 14, Lausanne. Bernard.Waeber@chuv.ch
authors.forename: B
authors.initials: B
authors.lastname: Waeber
authors.forename: F
authors.initials: F
authors.lastname: Feihl
mesh_terms: D015415:Biomarkers / Q000097:blood; D006801:Humans; D006973:Hypertension / Q000097:blood* / Q000150:complications / Q000175:diagnosis; D017379:Hypertrophy, Left Ventricular / Q000097:blood* / Q000175:diagnosis / Q000209:etiology; D045283:Natriuretic Agents / Q000097:blood*; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D011237:Predictive Value of Tests; D018570:Risk Assessment; D012307:Risk Factors; D012680:Sensitivity and Specificity
chemical_list: D015415:Biomarkers; D045283:Natriuretic Agents; D020097:Natriuretic Peptide, Brain